• Publications
  • Influence
Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea-hypopnoea (TOMADO) and long-term
BACKGROUND Obstructive sleep apnoea-hypopnoea (OSAH) causes excessive daytime sleepiness (EDS), impairs quality of life (QoL) and increases cardiovascular disease and road traffic accident risks.Expand
  • 31
  • 3
  • PDF
S1 TOMADO: A crossover randomised controlled trial of oral mandibular advancement devices for obstructive sleep apnoea-hypopnoea
Introduction Obstructive sleep apnoea-hypopnoea (OSAH) causes excessive daytime sleepiness (EDS), impairs quality of life (Qol), and increases cardiovascular disease and road traffic accident risks.Expand
  • 2
  • 1
S115 Hot-hmv uk trial secondary outcome analysis: early readmission is reduced by the addition of home mechanical ventilation to home oxygen therapy in copd patients with chronic respiratory failure
Introduction Hospital readmission following treatment for a life-threatening exacerbation of COPD with acute NIV is frequent and associated with an adverse impact in terms of lung function and healthExpand
  • 3
Epworth Sleepiness Scale
  • 1
S135 Long-term outcomes in patients referred to a specialised weaning centre; The impact of referral source, non-invasive ventilation and diagnosis
Introduction The expansion of specialised weaning centres serving networks of external ICUs has been recommended by the NHS commissioning board. However, data are limited for this proposed model ofExpand
  • 1
P253 Obstructive sleep apnoea syndrome: Patients’ experience of the driver and vehicle licensing agency
Introduction Driver’s licence holders have a legal obligation to inform the Driver and Vehicle Licensing Authority (DVLA) if diagnosed with Obstructive Sleep Apnoea Syndrome (OSAS). This requirementExpand
Summary of protocol changes